Early Gene Therapy Trial Brings New Hope for Tay-Sachs and Sandhoff Diseases
A recent Phase I/II clinical study led by UMass Chan Medical School has shown encouraging results for a gene therapy targeting GM2 gangliosidosis, a group of rare and fatal neurodegenerative…